Citadel Advisors’s TearLab Corporation TEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,078
Closed -$5K 8502
2016
Q4
$5K Buy
+1,078
New +$6.13K ﹤0.01% 7166
2015
Q2
Sell
-1,625
Closed -$32K 9349
2015
Q1
$32K Sell
1,625
-1,519
-48% -$36.5K ﹤0.01% 7669
2014
Q4
$83K Buy
3,144
+2,506
+393% +$69K ﹤0.01% 6805
2014
Q3
$22K Buy
+638
New +$27K ﹤0.01% 7376
2013
Q3
Sell
-1,789
Closed -$190K 6997
2013
Q2
$190K Buy
+1,789
New +$164K ﹤0.01% 4718

Other funds holding TEAR

Citadel Advisors's TEAR Position: Q1 2017 in Review

Citadel Advisors sold out of TearLab Corporation (TEAR) in Q1 2017, closing a stake of 1,078 shares — an estimated $5K sold.

Citadel Advisors first reported a position in TEAR in Q2 2013 and held it in 5 quarters. The position peaked at $190K in Q2 2013. 18 funds tracked by Wall St. Rank hold TEAR as of Q1 2017.

  • Citadel Advisors reported no remaining TearLab Corporation position as of Q1 2017 after selling out during the quarter.
  • Citadel Advisors sold 1,078 TearLab Corporation shares in Q1 2017, an estimated $5K.
  • Citadel Advisors first reported a position in TearLab Corporation in Q2 2013 and held it in 5 quarters.
  • Citadel Advisors's TearLab Corporation position peaked at $190K in Q2 2013.
  • 18 funds tracked by Wall St. Rank held TearLab Corporation as of Q1 2017.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.